Even though we don't know the data for the DIPG study yet, I'm assuming the FDA does and they used that to make this determination. Must mean the data is very good so far.
- Forums
- ASX - By Stock
- KZA
- Ann: Kazia's paxalisib obtains Rare Pediatric Disease Designation
Ann: Kazia's paxalisib obtains Rare Pediatric Disease Designation, page-16
-
-
- There are more pages in this discussion • 87 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add KZA (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
LU7
LITHIUM UNIVERSE LIMITED
Alex Hanly, CEO
Alex Hanly
CEO
SPONSORED BY The Market Online